drugset
Drugs / Cold Stored Platelets
last change Apr 2025 re-read 3 minutes ago

Cold Stored Platelets

also known as CSP
Developed for
hemorrhagic disease · platelet disorder, undefined · traumatic brain injury
Investigated by
United States Department of Defense · Jason Sperry · Moritz Stolla, MD · Philip Spinella · University of Minnesota · University of Pittsburgh
+2 more · University of Utah · Washington University School of Medicine

Trials 4

today NCT04667468 · Ph 2 NCT04726410 · Ph 2 NCT05220787 · Ph 1/2 NCT04834414 · Ph 3
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT05220787 Feb 2022 → Oct 2024 hemorrhagic disease, platelet disorder, undefined Moritz Stolla, MD Unknown No outcome recorded
Phase 22 trials
Phase 2 NCT04667468 Jun 2022 → Oct 2023 hemorrhagic disease Jason Sperry Completed No outcome recorded
Phase 2 NCT04726410 Mar 2022 → May 2024 traumatic brain injury Jason Sperry Completed No outcome recorded
Phase 31 trial
Phase 3 NCT04834414 Oct 2021 → Mar 2025 — Philip Spinella Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Cold Stored Platelets ClinicalTrials.gov intervention name — accepted as the source's own label NCT04726410 ↗
3

NCT04667468 ↗

NCT05220787 ↗

NCT04834414 ↗
Known as CSP “Cold Stored Platelets (CSP)” NCT04667468 ↗